Similarly, puerarin was showed to alleviate TAA-induced liver fibrosis by reducing HSC activation and alleviating ECM expression through the downregulation of the TGF-β/ERK1/2 pathway [42]. Here, TGFB1 is linked to Hepatic fibrosis.